logo
AAT Bioquest

C-C chemokine receptor type 5 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
MaravirocIC500.43 [1]
TAK-779 cationIC501.4 [1]
1-Butyl-3-(2-methylpropyl)-9-[(4-phenoxyphenyl)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC5094.0 [1]
Aplaviroc hydrochlorideIC5034.0 [1]
1,4,9-Triazaspiro[5.5]undecane-2,5-dione, 1-butyl-3-(cyclohexylmethyl)-9-[(4-phenoxyphenyl)methyl]-IC5028.0 [1]
N-[(2S)-2-(3-Chlorophenyl)-4-(1-oxospiro[2H-1-benzothiophene-3,4'-piperidine]-1'-yl)butyl]-N-methylbenzenesulfonamideIC5010.0 [1]
(2R)-2-[(3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acidIC501.2 [1], 2.0 [2], 2.1 [3]
(4,6-Dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanoneIC501.5 [1], 3.0 [2], 16.0 [3]
(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-9-[(4-phenoxyphenyl)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC507.76 [1], 53.0 [2], 7800.0 [3], 53000.0 [4]
VicrivirocIC500.45 [1], 1.2 [2], 3.0 [3]
VicrivirocKi2.1 [1], 2.5 [2]
N-[(2S)-2-(3,4-Dichlorophenyl)-4-(1-oxospiro[2H-1-benzothiophene-3,4'-piperidine]-1'-yl)butyl]-N-methylbenzenesulfonamideIC5035.0 [1]
[4-[4-(4-Bromoanilino)-1-piperidyl]-4-methyl-1-piperidyl]-(2,6-dimethylphenyl)methanoneIC500.5 [1], 2.2 [2], 28.3 [3]
[4-[4-(4-Bromoanilino)-1-piperidyl]-4-methyl-1-piperidyl]-(2,6-dimethylphenyl)methanoneKi7.0 [1]
[4-[4-(N-Benzylanilino)piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanoneIC502.0 [1], 5.1 [2], 14.9 [3]
(4-(4-(Benzyl(phenyl)amino)piperidin-1-yl)-4-methylpiperidin-1-yl)(2,6-dimethylphenyl)methanoneIC501.4 [1], 3.0 [2], 12.2 [3], 14.4 [4]
(2,6-Dimethylphenyl)(4-(4-(diphenylamino)piperidin-1-yl)-4-methylpiperidin-1-yl)methanoneIC500.7 [1], 2.6 [2], 14.4 [3], 15.3 [4]
(4,6-Dimethyl-1-oxidopyrimidin-1-ium-5-yl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC502.9 [1], 12.0 [2], 13.3 [3], 24.0 [4]
(4,6-Dimethyl-2-pyridin-4-ylpyrimidin-5-yl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC502.8 [1], 7.9 [2], 24.6 [3], 30.0 [4]
6,8-Bis[(Z)-dec-1-enyl]-5,7-dimethyl-2,3-dihydro-1H-indolizin-4-ium;2,2,2-trifluoroacetateIC501000.0 [1], 5400.0 [2], 5430.0 [3]
[(2S)-2-(3-Chlorophenyl)-4-(4-phenylpiperidyl)butyl]methyl(phenylsulfonyl)amineIC5030.0 [1], 10000.0 [2]
(4,6-Dimethylpyrimidin-5-yl)-[4-methyl-4-[(3S)-3-methyl-4-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]piperazin-1-yl]piperidin-1-yl]methanoneIC500.01 [1]
(4,6-Dimethylpyrimidin-5-yl)-[4-methyl-4-[(3S)-3-methyl-4-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]piperazin-1-yl]piperidin-1-yl]methanoneKi2.8 [1], 3.0 [2]
Benzyl N-[1-[(3S)-4-[benzenesulfonyl(methyl)amino]-3-phenylbutyl]piperidin-4-yl]-N-ethylcarbamateIC502.0 [1], 7.0 [2]
(3R)-1-Butyl-3-[(1R)-1-hydroxy-2-methylpropyl]-9-[(4-phenoxyphenyl)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC503.5 [1], 33.0 [2], 84.0 [3], 229.09 [4]
3-[(N-[1-[1-(2,4-Dimethyl-1-oxidopyridin-1-ium-3-carbonyl)-4-methylpiperidin-4-yl]piperidin-4-yl]anilino)methyl]benzonitrileIC500.6 [1], 2.8 [2], 10.8 [3]
(2,4-Dimethylpyridin-3-yl)(4-(4-(diphenylamino)piperidin-1-yl)-4-methylpiperidin-1-yl)methanoneIC501.1 [1], 2.3 [2], 11.0 [3]
(4,6-Dimethylpyrimidin-5-yl)(4-(4-(diphenylamino)piperidin-1-yl)-4-methylpiperidin-1-yl)methanoneIC501.0 [1], 2.2 [2], 7.9 [3]
(2,4-Dimethyl-1-oxidopyridin-1-ium-3-yl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC503.3 [1], 3.4 [2], 16.0 [3]
4-[4-[[(3S)-1-Butyl-3-[(S)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochlorideIC5051.0 [1], 446.68 [2], 51000.0 [3], 447000.0 [4]
(4,6-Dimethyl-2-phenylpyrimidin-5-yl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC508.5 [1], 16.5 [2], 23.0 [3], 31.0 [4]
1,4,9-Triazaspiro[5.5]undecane-2,5-dione, 1-butyl-3-(cyclohexylmethyl)-9-[(4-methoxyphenyl)methyl]-IC504.5 [1], 120.0 [2]
Rac-9-Benzyl-1-butyl-3-isobutyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochlorideIC50560.0 [1], 900.0 [2]
4-[4-[[(3S)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acidIC50380.19 [1], 470.0 [2], 380000.0 [3], 470000.0 [4]
4-[4-[[(3R)-1-Butyl-3-[(S)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acidIC5044.0 [1], 181.97 [2], 44000.0 [3], 182000.0 [4]
CenicrivirocIC500.1 [1], 3.0 [2], 3.1 [3]
(2,4-Dimethylpyridin-3-yl)-[4-methyl-4-[(3S)-3-methyl-4-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]piperazin-1-yl]piperidin-1-yl]methanoneKi2.0 [1], 2.3 [2]
Unii-61xqn688TWIC500.32 [1]
NifevirocIC502.9 [1], 3.5 [2]
(4-Nitrophenyl)methyl N-[1-[[(3S,4S)-1-(2-chlorobenzoyl)-4-phenylpyrrolidin-3-yl]methyl]piperidin-4-yl]-N-prop-2-enylcarbamateIC500.8 [1]
(2,4-Dimethyl-1-oxidopyridin-1-ium-3-yl)-[4-methyl-4-[(3S)-3-methyl-4-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]piperazin-1-yl]piperidin-1-yl]methanoneKi7.0 [1]
(2R)-2-[(3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-3-methylbutanoic acidIC501.5 [1]
(2R)-2-[(3S,4S)-3-[[4-(5-Benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-3,3-dimethylbutanoic acidIC500.8 [1]
4-(2-(4-Chlorobenzyloxy)-5-bromobenzyl)morpholineIC501000.0 [1]
1-[5-Bromo-2-[(4-chlorophenyl)methoxy]phenyl]-N,N-dimethyl-methanamineIC50599.79 [1], 600.0 [2]
N-[[5-Bromo-2-[(4-chlorophenyl)methoxy]phenyl]methyl]-N-ethyl-ethanamineIC501399.59 [1], 1400.0 [2]
(2R)-3-Cyclobutyl-2-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]propanoic acidIC500.1 [1]
N-[(2S)-2-(3-Chlorophenyl)-4-(1,1-dioxospiro[2H-1-benzothiophene-3,4'-piperidine]-1'-yl)butyl]-N-methylbenzenesulfonamideIC5015.0 [1], 1000.0 [2]
N-[(2S)-2-(3,4-Dichlorophenyl)-4-(1,1-dioxospiro[2H-1-benzothiophene-3,4'-piperidine]-1'-yl)butyl]-N-methylbenzenesulfonamideIC50100.0 [1], 399.94 [2]
N-[(2S)-2-(3,4-Dichlorophenyl)-4-spiro[2H-1-benzothiophene-3,4'-piperidine]-1'-ylbutyl]-N-methylbenzenesulfonamideIC50399.94 [1], 1000.0 [2]
N-[(2S)-2-(3-Chlorophenyl)-4-(3-oxospiro[2H-indene-1,4'-piperidine]-1'-yl)butyl]-N-methylbenzenesulfonamideIC505.0 [1], 3396.25 [2]
N-[(2S)-2-(3-Chlorophenyl)-4-spiro[2H-1-benzothiophene-3,4'-piperidine]-1'-ylbutyl]-N-methylbenzenesulfonamideIC50270.0 [1], 599.79 [2]
1-[[(3S,4S)-1-(Cyclohexylmethyl)-4-phenylpyrrolidin-3-yl]methyl]-4-[3-[4-(2H-tetrazol-5-yl)phenyl]propyl]piperidin-4-olIC500.2 [1]
N-[(1S)-3-[(1R,5S)-3-(2-Methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclobutanecarboxamideIC502.0 [1], 6.0 [2]
[(3S,4S)-3-Phenyl-4-[[4-[propyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]-pyrrolidin-1-ylmethanoneIC509.0 [1], 300.0 [2]
Cyclobutyl-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanoneIC5010.0 [1], 300.0 [2]
Cyclohexyl-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyridin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanoneIC5012.0 [1], 100.0 [2]
Cyclohexyl-[(3S,4S)-3-phenyl-4-[[4-[prop-2-enyl(pyridin-3-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanoneIC5012.0 [1], 23.0 [2]
Cyclohexyl-[(3S,4S)-3-phenyl-4-[[4-[prop-2-enyl(pyrimidin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]methanoneIC5012.0 [1]
(2R)-2-Cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyridin-3-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acidIC505.0 [1], 33.0 [2]
(2R)-2-Cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-[propyl(pyrimidin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acidIC506.6 [1], 33.0 [2]
(2,4-Dimethyl-1-oxidopyridin-1-ium-3-yl)-[4-methyl-4-[4-(N-pyridin-3-ylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC505.1 [1], 16.2 [2], 43.6 [3]
1-Butyl-3-(2-methylpropyl)-9-(6-phenylhexyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC5038.0 [1], 270.0 [2]
(3R)-1-Butyl-3-(2-methylpropyl)-9-[(4-phenoxyphenyl)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC5029.0 [1], 130.0 [2]
4-[(N-[1-[1-(2,4-Dimethyl-1-oxidopyridin-1-ium-3-carbonyl)-4-methylpiperidin-4-yl]piperidin-4-yl]anilino)methyl]benzonitrileIC503.8 [1], 140.0 [2], 350.0 [3]
[4-[4-(4-Chloroanilino)-1-piperidyl]-4-methyl-1-piperidyl]-(2,6-dimethylphenyl)methanoneIC502.0 [1], 2.4 [2], 25.7 [3]
(2,6-Dimethylphenyl)-[4-methyl-4-[4-[4-(trifluoromethyl)anilino]-1-piperidyl]-1-piperidyl]methanoneIC500.8 [1], 1.1 [2], 27.3 [3]
(2,6-Dimethylphenyl)-[4-methyl-4-[4-[(1-methylindol-7-yl)amino]-1-piperidyl]-1-piperidyl]methanoneIC50102.0 [1], 147.0 [2], 2165.0 [3]
(2,6-Dimethylphenyl)-[4-methyl-4-[4-[(1-methylindol-6-yl)amino]-1-piperidyl]-1-piperidyl]methanoneIC5043.0 [1], 91.0 [2], 1680.0 [3]
[4-[4-(N-Benzyl-4-bromoanilino)piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,6-dimethylphenyl)methanoneIC502.3 [1], 6.2 [2], 15.6 [3]
(2-Methylphenyl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC507.8 [1], 28.6 [2], 67.0 [3]
[4-Methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]-phenylmethanoneIC50200.0 [1], 453.0 [2], 511.0 [3]
(2,6-Dichlorophenyl)-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC502.4 [1], 3.5 [2], 7.9 [3]
1H-Indol-4-yl-[4-methyl-4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC509.9 [1], 31.0 [2], 102.0 [3]
(2,6-Dimethylphenyl)-[4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC5011.1 [1], 26.0 [2], 61.0 [3]
(2,4-Dimethylpyridin-3-yl)-[4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC503.0 [1], 7.4 [2], 15.5 [3]
(2,4-Dimethyl-1-oxidopyridin-1-ium-3-yl)-[4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC509.0 [1], 117.0 [2], 127.0 [3]
(4,6-Dimethylpyrimidin-5-yl)-[4-[4-(N-phenylanilino)piperidin-1-yl]piperidin-1-yl]methanoneIC508.2 [1], 48.0 [2], 62.0 [3]
[1-[(1S,2S)-2-[(S)-Hydroxy-[(2R)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoateIC507200.0 [1], 10000.0 [2]
CID 9810893IC500.24 [1], 1.4 [2], 1.7 [3]
(2R)-3-Cyclobutyl-2-[(3S,4S)-3-(3-fluorophenyl)-4-[[4-[propyl(pyrimidin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]propanoic acidIC501.8 [1], 11.0 [2]
1-Butyl-3-(cyclohexylmethyl)-9-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochlorideIC502.5 [1], 20.0 [2], 50.0 [3]
Rac-3-Isobutyl-9-(4-phenoxybenzyl)-1-propyl-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochlorideIC5017.0 [1], 500.0 [2]
1-Butyl-9-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-3-(2-methylpropyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dioneIC5020.0 [1], 170.0 [2], 180.0 [3]
(3S)-1-Butyl-3-isobutyl-9-(4-phenoxybenzyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione hydrochlorideIC5011.0 [1], 84.0 [2]
(5R)-1-[1-[4-(Pyrimidine-5-yl)benzyl]piperidine-4-yl]-3-cyclohexyl-5-phenylimidazolidine-2-oneIC5017.3 [1], 18.9 [2], 50.6 [3]
4-[4-[[(3S)-1-Butyl-3-(cyclohexylmethyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acidIC5013.0 [1], 87.1 [2]
[1-[(1S,2S)-2-[(S)-Hydroxy-[(2R)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl] (Z)-3-(4-methoxyphenyl)prop-2-enoateIC506000.0 [1], 8800.0 [2], 10000.0 [3]
6-[2-(Dimethylamino)ethyl-methylamino]-1,3-dimethyl-N-[(3-propan-2-yloxyphenyl)carbamoyl]pyrazolo[3,4-b]pyridine-5-carboxamide;hydrochlorideIC50400.0 [1], 10000.0 [2]
4-[4-[[4-[(5R)-3-Cyclohexyl-2-oxo-5-phenyl-imidazolidin-1-yl]-1-piperidyl]methyl]phenoxy]benzamideIC506.9 [1], 18.0 [2], 28.8 [3]
4-[4-[4-[(5R)-2-Oxo-3-cyclohexyl-5-phenylimidazolidine-1-yl]piperidinomethyl]phenoxy]benzoic acidIC506.4 [1], 13.0 [2], 38.9 [3]
6-Chloro-N-[3-[4-[(5R)-3-cyclobutyl-2-oxo-5-phenylimidazolidin-1-yl]piperidin-1-yl]butyl]-2,4-dimethylpyridine-3-carboxamideIC501.7 [1], 2.3 [2], 19.5 [3]
4-[[(4R)-3-[1-[4-[(6-Chloro-2,4-dimethylpyridine-3-carbonyl)amino]butan-2-yl]piperidin-4-yl]-2-oxo-4-phenylimidazolidin-1-yl]methyl]benzoic acidIC501.0 [1], 3.6 [2], 42.2 [3]
N-[3-[4-[5-(3-Chlorophenyl)-3-cyclohexyl-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamideIC502.5 [1], 5.8 [2], 19.5 [3]
N-[3-[4-[3-Cyclohexyl-5-(3-fluorophenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamideIC5015.0 [1], 25.9 [2], 62.5 [3]
N-[3-[4-[5-(3-Cyanophenyl)-3-cyclohexyl-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamideIC5032.2 [1], 34.8 [2], 56.9 [3]
Methyl 3-[1-cyclohexyl-3-[1-[4-[(4,6-dimethylpyrimidine-5-carbonyl)amino]butan-2-yl]piperidin-4-yl]-2-oxoimidazolidin-4-yl]benzoateIC50157.6 [1], 175.8 [2], 346.5 [3]
N-[3-[4-[3-Cyclohexyl-5-(3,5-dimethylphenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamideIC504.7 [1], 36.5 [2], 79.6 [3]
N-[3-[4-[3-Cyclohexyl-5-(3-fluoro-5-methylphenyl)-2-oxoimidazolidin-1-yl]piperidin-1-yl]butyl]-4,6-dimethylpyrimidine-5-carboxamideIC507.1 [1], 18.5 [2], 32.0 [3]
6-Chloro-2,4-dimethyl-N-[3-[4-[(5R)-2-oxo-5-phenyl-3-propylimidazolidin-1-yl]piperidin-1-yl]butyl]pyridine-3-carboxamideIC506.4 [1], 7.5 [2], 19.4 [3]



References

This online tool may be cited as follows

MLA

"Quest Database™ C-C chemokine receptor type 5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Nov2024https://www.aatbio.com/data-sets/c-c-chemokine-receptor-type-5-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 21). Quest Database™ C-C chemokine receptor type 5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/c-c-chemokine-receptor-type-5-inhibitors-ic50-ki.
BibTeXEndNoteRefMan